BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12288974)

  • 21. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S; Charoenvisal C; Banharnsupawat L; Singhakovin S; Kaewsuk O; Punnahitanont S
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinolytic response in women on low-dose oral contraceptive.
    Ishak R; Ahmad R; Gudum HR; Hassan K; Ang ES
    Malays J Reprod Health; 1992 Jun; 10(1):7-11. PubMed ID: 12345026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure changes and hormonal contraceptives.
    Shen Q; Lin D; Jiang X; Li H; Zhang Z
    Contraception; 1994 Aug; 50(2):131-41. PubMed ID: 7956212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
    Fioretti P; Fruzzetti F; Navalesi R; Ricci C; Miccoli R; Cerri M; Orlandi MC; Melis GB
    Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the plasma levels of proteins C and S in young women on low-dose oestrogen oral contraceptives.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; De Luca P; Egitto M; Granese D; Pullè C; Trimarchi F
    Clin Exp Obstet Gynecol; 1991; 18(1):9-12. PubMed ID: 1829030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptive pills and the risk of venous thromboembolism.
    Prog Hum Reprod Res; 1996; (39):2-3. PubMed ID: 12292198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Veins and contraception].
    Reinharez D; Monsonego J
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD; Lawrenson RA
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of desogestrel-containing oral contraceptives on vascular reactivity and catecholamine levels.
    Arangino S; Cagnacci A; Angiolucci M; Longu G; Melis GB; Volpe A
    Contraception; 1998 Nov; 58(5):289-93. PubMed ID: 9883384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
    Nichols M; Robinson G; Bounds W; Newman B; Guillebaud J
    Contraception; 1993 Apr; 47(4):367-76. PubMed ID: 8508666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the effects of three different kinds of oral contraceptives on lipoprotein and apolipoprotein metabolism].
    Yang PJ; He ML; Li LM; Gui YL; Chen JK
    Shengzhi Yu Biyun; 1993 Feb; 13(1):37-43. PubMed ID: 12318281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation studies in women on combination type of oral contraceptives.
    Gupta K; Nain S; Manikeri S; Sheth UK; Vaidya P; Mandlekar A; Krishna UR
    J Obstet Gynaecol India; 1979 Jun; 29(3):647-9. PubMed ID: 12335923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
    Prasad RN; Koh S; Ratnam SS
    Contraception; 1989 Apr; 39(4):369-83. PubMed ID: 2524360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.